KOTAI Biotechnologies, Inc. focuses on developing innovative biotechnological solutions aimed at addressing critical challenges in healthcare and agriculture. The company leverages advanced genetic engineering techniques to create novel therapeutics and agricultural products. Their pipeline includes a range of biopharmaceuticals designed to target specific diseases, as well as bio-based solutions that enhance crop resilience and productivity. KOTAI's commitment to research and development is evident in their robust portfolio, which aims to improve patient outcomes and promote sustainable agricultural practices.

The technologies employed by KOTAI Biotechnologies encompass cutting-edge methodologies in synthetic biology and molecular biology. By utilizing these techniques, the company is able to manipulate biological systems at the genetic level, enabling the design of tailored solutions that meet specific needs in both medical and agricultural fields. Their scientific approach emphasizes precision and efficacy, ensuring that their products not only meet regulatory standards but also provide significant benefits to end-users. Through continuous innovation and a focus on scientific excellence, KOTAI Biotechnologies is positioned to make a meaningful impact in the biotechnology sector.

Japan

KOTAI Biotechnologies, Inc. (KOTAI, Osaka, Japan) is a spinout from Osaka University's world leading research center, Immunology Frontier Research Center launched in 2016.
Our unique and sophisticated bioinformatics based on deep structure understandings has enabled us to analyze high throughput sequencing data of the immune systems such as Immune repertoire (BCR, TCR, antibodies, etc) and RNA-seq data. KOTAI is working on discoveries of new biomarkers and therapeutic compounds through the repertoire analysis.

KOTAI Biotechnologies, Inc.

Company Details